KRISTEN BEVILL: Open Payments
NPI 1841315546 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 125 payments from 20 companies in 2025. Trend: 2023 $2,019 · 2024 $1,793 · 2025 $2,156
Food & beverage: $2,156
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 29 | $474 |
| Janssen Pharmaceuticals, Inc | 11 | $251 |
| Otsuka America Pharmaceutical, Inc. | 23 | $249 |
| ABBVIE INC. | 12 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $151 |
| Teva Pharmaceuticals USA, Inc. | 7 | $143 |
| Axsome Therapeutics, Inc. | 8 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $133 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| E.R. Squibb & Sons, L.L.C. | 5 | $85 |
Products named: REXULTI, ABILIFY ASIMTUFII, SPRAVATO, VRAYLAR, TRINTELLIX, UZEDY, Auvelity, CAPLYTA.
Industry payments across MS — which companies pay providers there.
